Prestige Consumer Healthcare Overview
- Year Founded
-
1996
- Status
-
Public
- Employees
-
570
- Stock Symbol
-
PBH
- Investments
-
28
- Share Price
-
$79.77
- (As of Wednesday Closing)
Prestige Consumer Healthcare General Information
Description
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Contact Information
Website
www.prestigebrands.comCorporate Office
- 4615 Murray Place
- Lynchburg, VA 24502
- United States
Corporate Office
- 4615 Murray Place
- Lynchburg, VA 24502
- United States
Prestige Consumer Healthcare Stock Performance
As of 23-Apr-2025, Prestige Consumer Healthcare’s stock price is $79.77. Its current market cap is $3.95B with 49.5M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $79.77 | $80.23 | $62.35 - $90.04 | $3.95B | 49.5M | 366K | $4.30 |
Prestige Consumer Healthcare Financials Summary
As of 31-Dec-2024, Prestige Consumer Healthcare has a trailing 12-month revenue of $1.12B.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Mar-2024 | FY 2023 31-Mar-2023 | FY 2022 31-Mar-2022 |
|---|---|---|---|---|
| EV | 4,867,412 | 4,752,448 | 4,473,290 | 4,198,203 |
| Revenue | 1,118,235 | 1,125,357 | 1,127,725 | 1,086,812 |
| EBITDA | 360,449 | 373,860 | 7,874 | 358,837 |
| Net Income | 213,935 | 209,339 | (82,306) | 205,381 |
| Total Assets | 3,329,497 | 3,318,417 | 3,353,729 | 3,670,681 |
| Total Debt | 1,027,132 | 1,139,656 | 1,367,091 | 1,506,359 |
Prestige Consumer Healthcare Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Prestige Consumer Healthcare Comparisons
Industry
Financing
Details
Prestige Consumer Healthcare Competitors (2)
One of Prestige Consumer Healthcare’s 2 competitors is Haleon, a Corporation company based in Weybridge, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Haleon | Corporation | Weybridge, United Kingdom | ||||
| Glaxosmithkline Consumer Healthcare | Corporate Backed or Acquired | Gurugram, India |
Prestige Consumer Healthcare Patents
Prestige Consumer Healthcare Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230277387-A1 | Pad and method of use for removing callus | Pending | 03-Mar-2022 | ||
| CA-3139734-A1 | Borate ester complexes of a-hydroxy carboxylic acids and their conjugate base buffers | Pending | 23-Nov-2020 | ||
| US-20220162234-A1 | Borate ester complexes of a-hydroxy carboxylic acids and their conjugate base buffers | Pending | 23-Nov-2020 | ||
| US-10426834-B1 | Methods of sterilizing drugs | Inactive | 11-Aug-2016 | ||
| US-9517269-B1 | Stable pentobarbital formulation | Inactive | 01-Oct-2013 | A61K47/10 |
Prestige Consumer Healthcare Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Prestige Consumer Healthcare Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Prestige Consumer Healthcare Investments & Acquisitions (28)
Prestige Consumer Healthcare’s most recent deal was a Corporate Asset Purchase with Hydralyte (IP Rights in all Relevant Jurisdictions) for . The deal was made on 02-Oct-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Hydralyte (IP Rights in all Relevant Jurisdictions) | 02-Oct-2024 | Corporate Asset Purchase | Buildings and Property | ||
| Akorn (Consumer Health Business) | 01-Jul-2021 | Merger/Acquisition | Pharmaceuticals | ||
| TheraTears | 01-Jul-2021 | Merger/Acquisition | Medical Supplies | ||
| Fleet Laboratories | 26-Jan-2017 | Merger/Acquisition | Pharmaceuticals | ||
| DenTek Oral Care | 05-Feb-2016 | Merger/Acquisition | Personal Products |
Prestige Consumer Healthcare ESG
Risk Overview
Risk Rating
Updated December, 04, 2024
32.99 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,109
Rank
Percentile
Pharmaceuticals
Industry
of 861
Rank
Percentile
Pharmaceuticals
Subindustry
of 430
Rank
Percentile
Prestige Consumer Healthcare Exits (7)
Prestige Consumer Healthcare’s most recent exit was on 02-May-2014 from Hydralyte. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Hydralyte | 02-May-2014 | Completed |
|
||
| Chore Boy | 28-Oct-2005 | Completed |
|
||
| Comet Cleanser | 01-Oct-2001 | Completed |
|
||
| Cutex Brands | 01-Dec-1998 | Completed |
|
||
| New Skin | 01-Jan-1996 | Buyout/LBO | Completed |
|
Prestige Consumer Healthcare Affiliates
Subsidiaries (5)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| TheraTears | Woburn, MA | 1995 | |
| Care Pharmaceuticals | Bondi Junction, Australia | 1986 | |
| DenTek Oral Care | Maryville, TN | 1984 | |
| Chloraseptic | Tarrytown, NY | 1952 | |
| Spic and Span | Irvington, NY | 1925 |
Prestige Consumer Healthcare FAQs
-
When was Prestige Consumer Healthcare founded?
Prestige Consumer Healthcare was founded in 1996.
-
Where is Prestige Consumer Healthcare headquartered?
Prestige Consumer Healthcare is headquartered in Lynchburg, VA.
-
What is the size of Prestige Consumer Healthcare?
Prestige Consumer Healthcare has 570 total employees.
-
What industry is Prestige Consumer Healthcare in?
Prestige Consumer Healthcare’s primary industry is Personal Products.
-
Is Prestige Consumer Healthcare a private or public company?
Prestige Consumer Healthcare is a Public company.
-
What is Prestige Consumer Healthcare’s stock symbol?
The ticker symbol for Prestige Consumer Healthcare is PBH.
-
What is the current stock price of Prestige Consumer Healthcare?
As of 23-Apr-2025 the stock price of Prestige Consumer Healthcare is $79.77.
-
What is the current market cap of Prestige Consumer Healthcare?
The current market capitalization of Prestige Consumer Healthcare is $3.95B.
-
What is Prestige Consumer Healthcare’s current revenue?
The trailing twelve month revenue for Prestige Consumer Healthcare is $1.12B.
-
Who are Prestige Consumer Healthcare’s competitors?
Haleon and Glaxosmithkline Consumer Healthcare are competitors of Prestige Consumer Healthcare.
-
What is Prestige Consumer Healthcare’s annual earnings per share (EPS)?
Prestige Consumer Healthcare’s EPS for 12 months was $4.30.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
